Report: Clinical trials miss many populations
April 10th, 2008People with disabilities among those routinely excluded or under-represented
From HealthDay News in U.S. News & World Report:
A new analysis of the American clinical trial process suggests that the system for testing new drugs has routinely excluded or under-represented women, older people, minorities, disabled individuals and rural populations for decades.
“We’ve got a big problem,” said Daniel S. Goldberg, chief policy adviser for the report. “And it’s extremely urgent that we fix it. Because we’re trying to figure out how to streamline health care and make people healthy, of course. And the fact that we have under-representation in clinical trials undermines both of these goals and undermines the quality of the evidence we come up with.”
The report was conducted by the Chronic Disease Prevention & Control Research Center at Baylor College of Medicine in conjunction with the Intercultural Cancer Council, both based in Houston.
This entry was posted
on Thursday, April 10th, 2008 at 5:49 am and is filed under elderly, medicine, race, research news.
You can follow any responses to this entry through the RSS 2.0 feed.
You can leave a response, or trackback from your own site.
Email This Post
Our RSS Feed